UK markets closed

Sea Mild Biotechnology Co., Ltd. (7516.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
9.68+0.08 (+0.83%)
At close: 02:55PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
257,018
257,018
202,649
163,816
207,880
-
Cost of revenue
200,647
200,647
166,494
144,728
180,598
-
Gross profit
56,371
56,371
36,155
19,088
27,282
-
Operating expenses
Research development
3,384
3,384
2,974
4,904
4,995
-
Selling general and administrative
48,154
48,154
45,209
47,716
61,131
-
Total operating expenses
51,538
51,538
48,183
52,620
66,126
-
Operating income or loss
4,833
4,833
-12,028
-33,532
-38,844
-
Interest expense
965
965
681
832
1,124
-
Income before tax
6,132
6,132
-21,483
-41,995
-47,253
-
Income tax expense
-55
-55
-103
10,056
8,250
-
Income from continuing operations
6,187
6,187
-21,380
-52,051
-55,503
-
Net income
6,187
6,187
-21,380
-52,051
-55,503
-
Net income available to common shareholders
6,187
6,187
-21,380
-52,051
-55,503
-
Basic EPS
-0.01
-
-1.11
-2.70
-2.87
-10.84
Diluted EPS
-0.01
-
-1.11
-2.70
-2.87
-10.84
Basic average shares
19,309
-
19,309
19,309
19,309
14,683
Diluted average shares
19,309
-
19,309
19,309
19,309
14,683